Pharmacology Research Institute Northridge, CA - 91324

Pharmacology Research Institute is categorized under Research and Development Laboratories in Northridge, CA .

Pharmacology Research Institute was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Charles Wilcox at the company’s branch by writing to 8435 Reseda Boulevard, Northridge, California CA 91324 or by phoning (561) 383-5595. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Pharmacology Research Institute
Contact Person: Charles Wilcox
Address: 8435 Reseda Boulevard, Northridge, California 91324
Phone Number: (561) 383-5595
Website Address: priresearch.com
Annual Revenue (USD): Unknown
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Pharmacology Research Institute was started in 0 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Charles Wilcox for inquiries that concern Pharmacology Research Institute by calling the company number (561) 383-5595, as your correspondence is most welcome. Additionally, the physical location of the branch of Pharmacology Research Institute can be found at the coordinates as well as the street address 8435 Reseda Boulevard in Northridge, California 91324.

For its online presence, you may visit Pharmacology Research Institute’s website at priresearch.com and engage with its social media outlets through on Twitter and on Facebook.